GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently gaining a major focus in therapeutic research, largely Amanda peptide due to its notable impact on treating conditions such as adult-onset diabetes and excess body fat. Recent studies have revealed that beyond glucose management, GLP-1 drugs offer potential for cardiovascular